Argenica (ASX:AGN) granted Orphan Drug Designation by the FDA
An Orphan Designation opens up tax credits for clinical trials, user fee exemptions, and potentially seven years of market exclusivity.
An Orphan Designation opens up tax credits for clinical trials, user fee exemptions, and potentially seven years of market exclusivity.
An on-budget facility will enter commissioning production in January next year into a ready-made water filtration market.
High-grade results present a significant spodumene-bearing pegmatite swarm over 400 metres of strike.
Broad zones of oxide gold demonstrate mineralised continuity in lightly drilled areas and the likelihood of an upgraded resource.
An expansion catering to long-term industry demands results in an eightfold output of production under a finalised DFS.
LU7 appoints an experienced capital market operator to serve as Director of its Canadian subsidiary and open up international investment.
Cazaly Resources will test a 12km highly prospective lithium target in Namibia.
New targets include a soil anomaly extending over three kilometres at its tenement boundary with TG Metals.